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Abstract
Axonal transport is responsible for the movement of signals and cargo between nerve termini and cell bodies. Pathogens
also exploit this pathway to enter and exit the central nervous system. In this study, we characterised the binding,
endocytosis and axonal transport of an adenovirus (CAV-2) that preferentially infects neurons. Using biochemical, cell
biology, genetic, ultrastructural and live-cell imaging approaches, we show that interaction with the neuronal membrane
correlates with coxsackievirus and adenovirus receptor (CAR) surface expression, followed by endocytosis involving clathrin.
In axons, long-range CAV-2 motility was bidirectional with a bias for retrograde transport in nonacidic Rab7-positive
organelles. Unexpectedly, we found that CAR was associated with CAV-2 vesicles that also transported cargo as functionally
distinct as tetanus toxin, neurotrophins, and their receptors. These results suggest that a single axonal transport carrier is
capable of transporting functionally distinct cargoes that target different membrane compartments in the soma. We
propose that CAV-2 transport is dictated by an innate trafficking of CAR, suggesting an unsuspected function for this
adhesion protein during neuronal homeostasis.
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Introduction
Adenoviridae is a family of greater than 150 nonenveloped double-
stranded DNA viruses that infect all vertebrate classes. Whilst
adenoviruses (Ads) are commonly associated with respiratory,
ocular and gastrointestinal tract infections, many serotypes cause
clinical manifestations in other tissues, including the central
nervous system (CNS) [1–4]. Interest in Ad biology has been
rekindled by at least two events: Ads have re-emerged as life-
threatening pathogens in immunosuppressed hosts and young
military recruits [5], and they are currently the most common viral
vectors used in clinical gene transfer trials. Importantly, Ad
infections can be lethal in immunocompromised patients due to
genetic defects (SCID), during haematopoietic stem cell trans-
plants or by pharmacological agents (e.g. during solid organ
transplant) [2].
For brain-directed gene transfer, Ad vectors, in particular
canine serotype 2 (CAV-2) [6] have unique characteristics. In the
CNS of rodents, dogs and primates (including human tissue ex vivo),
CAV-2 vectors preferentially transduce neurons and undergo
efficient axonal transport ([7]; our unpublished data). We
previously demonstrated that following interstriatal injections in
rodents, CAV-2 was transported to afferent structures such as the
contralateral and ipsilateral cortex, substantia nigra, thalamus and
basal nuclei of Meynert [7–9]. In addition, following injection into
the mouse gastrocnemius, CAV-2 preferentially transduced motor
neurons of the sacral dorsolombar rachis [7]. CAV-2 vectors also
lead to .1 year in vivo transgene expression in rodent CNS [8,9]
without accompanying immunosuppression. In addition to their
potential in addressing fundamental neurobiological questions [9–
11], these molecular tools could also be used for treatment of
neurodegenerative disorders [12].
Although there are a handful of exceptions, most Ad attachment
and trafficking studies have used epithelial-like cells and serotypes
from human subgroup B, C and D (e.g. Ad2, 5, 35 and 37). Many
human serotypes, as well as CAV-2, bind with high affinity to the
coxsackievirus and adenovirus receptor (CAR) [13–16], a widely
expressed cell adhesion protein involved in tight junction
formation in epithelial cells and myocardial cells, and highly
expressed in the developing brain [17–21]. Many CAR-tropic Ads
are endocytosed in clathrin- and Rab5-associated pathways in
epithelial cells [22–24]. Following receptor-mediated internalisa-
tion, subgroups C Ads are thought to undergo a stepwise
disassembly, starting with detachment of the fibre from the virus
at the cell surface, followed by a passage through early endosomal
compartments in which acidification serves as a disassembly
trigger [25,26]. Although the mechanism is poorly understood,
intra-endosomal signals likely release vertex proteins, which may
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virion into the cytosol [25]. The metastable virions may then be
targeted via dynein and microtubule-dependent mechanisms
towards the nucleus in some cell types [28–30].
In spite of initial reports demonstrating that Ad vectors can be
transported retrogradely in neurons in vivo [31,32], little is known
concerning their brain cell receptors, the endosomal compart-
ment(s) entered during trafficking or the determinants for their
long-range transport. Axonal transport is crucial for neuronal
differentiation and homeostasis, which depend on the efficient
long-distance delivery (up to 1 meter in humans) of signals and
cargoes [33]. This pathway relies mainly on the microtubule-based
motors kinesins and cytoplasmic dynein, and their coordination
with F-actin-based motors [33,34]. Alterations in components of
the axonal transport machinery are associated with a growing
number of neurodegenerative conditions, including Alzheimer’s,
Parkinson’s, Huntington’s and motor neuron diseases [33,35]. In
spite of its importance, we are only beginning to understand how
the machinery of axonal transport is regulated.
The dual nature of Ads as ubiquitous pathogens and potential
gene transfer vectors for the CNS, imposes an in-depth analysis of
the molecular mechanisms involved in the virus-neuron interac-
tion. Here, we characterised the binding, internalisation and
axonal transport of an Ad that preferentially infects neurons. Our
data suggest that the neuronal binding of CAV-2 is CAR-
dependent and its internalisation involves clathrin-coated pits and
the small GTPase Rab5. In contrast to the established paradigm of
Ad trafficking in epithelial cells, long-range CAV-2 transport in
axons is mainly vesicular, and depends on the sequential
maturation of transported endosomes, which switch from Rab5
to Rab7. We found that CAV-2 axonal motility is bidirectional,
with a bias for the retrograde direction. Carriers of CAV-2 also
transported tetanus toxin and neurotrophin receptors and
surprisingly still contained CAR. We also demonstrated that
similarly to whole virions the fibre knob (FK) protein could be
found in CAR
+ organelles. We therefore propose that the intrinsic
neuronal properties of CAR are responsible for the efficient
trafficking of CAV-2 in neurons. More globally, our data
demonstrates that distinct receptor-mediated endocytic events
determine the sorting of diverse cargoes to nonacidic vesicles,
which are then recruited in a Rab7-dependent manner to the
long-range retrograde transport pathway, in a process that allows
selected pathogens to reach the CNS.
Results
CAV-2 binding correlates with CAR surface expression
and uptake involves clathrin-coated pits
CAV-2 vectors preferential infect neuronal cells in vivo and in
mixed brain cell cultures, however the binding determinants
responsible for this tropism have not been addressed. Although the
150 Ad serotypes can bind numerous co-receptors [36,37], our
previous studies suggested that CAR is the main receptor for
CAV-2 [16,38]. To study the neuronal link between CAR and
CAV-2, we incubated Cy3-labelled CAV-2 virions (CAV-Cy3)
with primary spinal cord motor neurons (MNs) on ice to allow
binding, but prevent internalisation. Cells were then fixed and
stained for endogenous CAR. Interestingly, CAR was found in two
distinct compartments in MNs. In addition to a plasma membrane
localisation seen also in sparse epithelial-like cells copurifying with
MNs, CAR was also found in a large intracellular pool (Figure
S1A). We found that .70% of CAV-Cy3 colocalised with CAR
on neurites in MNs and dorsal root ganglia neurons (DRG)
(Figures 1A, B and S1B). Moreover, when MNs were pre-
incubated with saturating concentrations of recombinant fibre
knob (FK), the adenovirus protein responsible for CAR binding,
and then treated with CAV-2, virion uptake was reduced by 76%
compared to control (Figure 1C).
We then examined the early steps of CAV-2 entry in MNs by
transmission electron microscopy (TEM). At 1 minute post-
internalisation, electron dense CAV-2 virions were associated
with structures resembling clathrin-coated pits, often present at
cell-to-cell contacts (Figures 1D, S1C and data not shown). By
indirect immunofluorescence, we also found extensive colocalisa-
tion between clathrin heavy chain and CAV-2 (Figure S1D).
These results are in good agreement with previous reports showing
that in epithelial cells, CAR-tropic Ads undergo clathrin-
associated endocytosis, and are consistent with our current
understanding of CAV-2 internalisation in these cells [16,39].
We next assessed CAV-2 internalisation in MNs. To this end, we
again incubated MNs with CAV-Cy3 on ice and then replaced the
medium with warm medium to induce internalisation. Cultures
were incubated at 37uC for 45 minutes, then shifted back to 4uC
and incubated with anti-Cy3 antibody to detect surface-bound
virions. We found that MNs internalised .75% of CAV-2 under
these conditions (Figure 1E).
Upon internalisation in epithelial cells, most CAR-tropic Ads
are believed to rapidly exit endosomal compartments to reach the
cytoplasm [30] from where the capsid may interact directly or
indirectly with cytoplasmic dynein [29], and be transported
towards the nucleus. To determine if a similar process was also at
the basis of the axonal transport of CAV-2, virions were incubated
with MNs at 4uC then shifted to 37uC, fixed at different times and
then visualized by TEM. At 2 to 5 minutes post-internalisation,
the majority (.90%) of the virions were inside intact endosomal
membranes (Figure 1F). Surprisingly, this pattern did not change
significantly (,90%) 30 to 45 minutes post-internalisation, when
live imaging of CAV-2 axonal transport was optimal (3
independent experiments, 97 virions in total; see below). At these
later time points, membrane-enveloped virions could be detected
close to structures morphologically similar to microtubule tracks
(Figure 1G, black arrow). Together these results suggest that CAV-
2 binds CAR, is endocytosed in clathrin-coated pits and,
Author Summary
Adenoviruses commonly cause subclinical morbidity in the
ocular, respiratory, and gastrointestinal tracts, and less
frequently, adenovirus-induced disease can be fatal for
newborns and immunocompromised hosts. In addition,
adenoviruses can reach the central nervous system (CNS)
and cause associated encephalitis and tumours. On the flip
side, during the last two decades, adenovirus vectors have
become powerful tools to treat and address diseases of
the CNS. Despite the fact that axonal transport of
adenoviruses was reported more than 15 years ago,
nothing was known concerning how adenoviruses access
the CNS. The characterization of their interactions with
brain cells was therefore long overdue. In this study, we
describe the axonal trafficking of an adenovirus that
preferentially infects neurons and reaches the CNS
through long-range axonal transport. We show that this
adenovirus exploits an endogenous vesicular pathway
used by the adhesion molecule CAR (coxsackievirus and
adenovirus receptor). Our study characterizes this endog-
enous route of access, which is likely to be crucial to
neuronal survival, neurodegenerative diseases, gene trans-
fer vectors, and adenovirus-induced morbidity.
Axonal Transport of CAV-2
PLoS Pathogens | www.plospathogens.org 2 May 2009 | Volume 5 | Issue 5 | e1000442Figure 1. CAV-2 binding and internalisation in MNs. (A) MNs and DRG were incubated with CAV-Cy3 (red) on ice, fixed and stained for total
(intracellular and plasma membrane bound) CAR (green). The white rectangle is enlarged to show colocalisation of CAV-2 and CAR on axons. (B)
Quantification of the colocalisation between CAV-2 and CAR in MNs (3 independent experiments, 149 virions total). The white bar corresponds to
colocalised CAV-Cy3 and CAR (yellow puncta) and the black bar corresponds to CAV-Cy3 alone (red puncta). Error bars (SEM) represent 7.2%. (C) CAV-
2 uptake is severely impaired by pre-treatment of MNs with an excess of recombinant FK (see Materials and Methods; 3 independent experiments,
670 (untreated) and 475 (FK) virions in total. Error bar represents 11.9%). (D, F and G) Ultrastructural analyses of CAV-2 entry in MNs. Cells treated
with CAV-2 were fixed at different time points and neurites imaged by TEM. (D) At early time-points (1 minute), CAV-2 was found associated
preferentially with structures resembling clathrin-coated pits (arrow). (E) MNs were incubated with CAV-Cy3 on ice and either fixed or shifted to 37uC
for 45 minutes to allow internalisation. Extracellular virions were revealed by using an anti-Cy3 antibody by IF and quantified (3 independent
experiments, 307 (4uC) and 522 (37uC) virions in total. Error bars represent 5.6% (4uC) and 10.7% (37uC)). (F) After 2 minutes of internalisation, CAV-2
was mainly present in vesicular structures (arrow) juxtaposed to the plasma membrane. (G) Endocytic tubule (white arrow) containing CAV-2 nearby
microtubule tracks (black arrow). Scale bars: (A) 5 mm; (D) 50 nm; (F, G) 100 nm.
doi:10.1371/journal.ppat.1000442.g001
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with microtubules in MNs.
Axonal transport of CAV-2 is bidirectional and vesicular in
cultured MNs
The above results prompted us to characterise the motility of
intracellular CAV-2 using established vesicular transport markers
by live cell imaging. Initially, we incubated CAV-Cy3 with
primary MNs, and axons were then imaged by confocal
microscopy. Using this approach, we detected bidirectional
transport of CAV-2 (Figure 2A and B, Video S1). Whilst the
majority (87%) of motile virions were transported towards the
soma, some (13%) showed anterograde movement (Figure 2C,
lower quadrant). In addition, some single virions changed
direction during imaging (Figure 2A and B, asterisk and red
dotted line), suggesting that either CAV-2 structures associates
with molecular motors of different polarity or that dynein-
dependent bidirectional transport [40] influences its kinetic
properties. Bidirectional CAV-2 transport, with a preference for
retrograde motility, was also found in cultures of embryonic DRG
(data not shown), suggesting a similar mechanism in sensory
neurons. The kinetics of transport were analysed by determining
the speed distribution profile of CAV-2 in MNs (Figure 2D). CAV-
2 retrograde transport appeared to be bimodal with peaks at 0.60
and 1.30 mm/s (Figure 2D, blue line), which is consistent with fast
retrograde transport [41]. In contrast, the anterograde transport
profile was more discontinuous (Figure 2D, red line).
While characterising CAV-2 transport kinetics, we noticed a
delay in the onset of long-range axonal transport. Although our
results suggested that CAV-2 is rapidly internalised (,5 min;
Figure 1F), we detected primarily oscillatory movements at early
times post-internalisation (Figure S2, top panel). Only after
25 minutes were we able to detect long-range movements (Figure
S2, middle panel), with robust vectorial transport beginning after
,30 minutes (Figure S2, middle and lower panels).
In contrast to the efficient escape from endosomes by CAR-
tropic Ads, our TEM data showed that the majority of CAV-2
remained trapped in vesicles when axonal transport is most
efficient. To directly address the possibility that CAV-2 axonal
transport is mediated by a membrane compartment, we co-
incubated MNs with CAV-Cy3 and AlexaFluor647-dextran,
which is a fluid phase marker used to identify endocytic organelles.
Consistent with our TEM observations, we found the majority
(,75%) of virions were co-transported with dextran (Figure 2E
and F). These data suggest that CAV-2 uses a vesicular transport
pathway to reach the MN soma.
Fast axonal transport of CAV-2 occurs in compartments
with pHs close to neutral
The stable association of CAV-2 with the endosomal lumen is
inconsistent with the canonical mechanism regulating productive
CAR-tropic Ad infections, and may represent a key determinant
for efficient axonal transport of CAV-2. Because the exit of Ads
from endosomes is triggered by the acidification of their lumen,
CAV-2 might enter nonacidic pH compartment(s) allowing its
stable sequestration during axonal transport. To test this
hypothesis, we assessed the association of CAV-2 with a fragment
of tetanus toxin (TeNT HC), which is internalised via a clathrin-
dependent mechanism coupled to axonal retrograde transport and
is sorted to carriers characterised by neutral pH [42,43]. To this
end, we co-incubated MNs with CAV-Cy3 and fluorescently-
labelled TeNT HC [41]. In fixed samples, CAV-Cy3 colocalised
with TeNT HC in axons and somas (Figure 3A). Furthermore,
using live-cell imaging we found that more than 85% of CAV-2
was co-transported with TeNT HC (Figure 3B and Video S2). Our
previous work showed that TeNT HC carriers also contain
neurotrophins and their receptors [44]. Accordingly, CAV-2
carriers were also positive for the neurotrophin receptor p75
NTR
(data not shown).
To directly assess the pH of the transport carriers containing
CAV-2, MNs were incubated with CAV-2 covalently labelled with
carboxyfluorescein (CAV-FC), a probe previously used to measure
the pH of endosomes reached by Ads during endocytosis [45].
CAV-FC-infected MNs were incubated with the ionophores
nigericin and monensin, exposed to L15 media at different pHs,
and the ratio of the emission intensities upon sequential excitation
at 458 and 488 nm was determined. Under these conditions, the
calibration curve of the pH-dependent fluorescence of CAV-FC
was obtained (Figure 3C). We then assayed the pH of CAV-FC-
containing structures in neurites compared to cell bodies
(Figure 3D). Consistent with the co-transport of CAV-2 with
TeNT HC, we found that the majority of axonal CAV-FC was
within a pH-range of 6 to 7 (Figures 3D). Interestingly, we detected
numerous acidic (pH,6) CAV-FC structures in the soma, whereas
only very few axonal CAV-FC could be observed at or below
pH 6 (Figure 3D).
To test the presence of CAV-2 in nonacidic structures in axons
using an alternative approach, MNs were incubated with CAV-
Cy3, AlexaFluor647-dextran and Lysotracker-488, a probe that is
sequestered in acidic compartments. Consistent with the above
results, axonal CAV-2/dextran-positive carriers were Lysotracker-
488-negative (Figure 3E). Furthermore, our quantitative analyses
of the extent of colocalisation between CAV-2 and lysotracker
confirmed the higher association of virions in acidic organelles in
cell bodies of MNs versus neurites (Figure 3F). Taken together,
these data demonstrate that the majority of CAV-2 is retrogradely
transported in axons inside a nonacidic vesicular compartment,
which is also used by endogenous ligands, receptors and other
pathogens.
Rab5 to Rab7 endosomal maturation is required for CAV-
2 transport
Progression along the endocytic pathway is tightly regulated in
time and space. In many cell types, the classical endosomal
pathway involves early endosomes containing Rab5, which then
mature into late endosomes characterised by the presence of Rab7
on their cytosolic face [46]. Because axonal transport of TeNT HC
requires the sequential activities of Rab5 and Rab7 [44], we asked
if these small GTPases were also associated with CAV-2 transport.
MNs were incubated with CAV-Cy3 for 5 or 45 minutes, fixed
and stained for endogenous Rab5 and Rab7. At 5 minutes post-
internalisation, we found numerous Rab5/CAV-2 structures
lacking Rab7, both in axons (Figure 4A) and in cell bodies (data
not shown), demonstrating that the virions associated with early
Rab5
+ endosomes immediately after internalisation. However, at
45 minutes post-internalisation we detected virions mainly in
Rab7
+ structures (Figure 4B). Quantitative analysis of the
distribution of Rab5, Rab7 and CAV-2 showed that at 5 minutes
post-internalisation, 40% of CAV-2 was in Rab5
+ compartments
whereas at 45 minutes post-internalisation, only 11% of the virions
colocalised with Rab5. In contrast, at 45 minutes 44% of virions
colocalised with Rab7, and 16% were Rab5/Rab7 double positive
(Figure 4C). These ratios are in good agreement with the
colocalisation between transported TeNT HC and Rab7 [44].
To address the functional relationship between CAV-2
transport and Rab7 activity, we microinjected MNs with plasmids
expressing GFP-tagged fusion proteins of either wild-type Rab7
Axonal Transport of CAV-2
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WT) or its dominant-negative N133I mutant (GFP-
Rab7
N133I) [47]. The axonal transport of CAV-2 was then assayed
using live-cell imaging in GFP and GFP-Rab7 expressing neurons.
In agreement with the degree of colocalisation observed with the
endogenous protein, CAV-Cy3 colocalised with GFP-Rab7
WT in
somas (Figure 4D) and axons (32%; 5 independent experiments,
107 virions in total) (Figure 4E and F). Furthermore, the GTPase
activity of Rab7 was essential for axonal transport of CAV-2 since
Figure 2. CAV-2 axonal transport in MNs. MNs were incubated with CAV-Cy3 for 45 minutes and imaged by time-lapse confocal microscopy
(100 frames; 0.2 frames/s). (A) Individual frames of a movie from a confocal time-series are shown. The cell body is located to the left. Arrowheads
show a virion being retrogradely transported, whereas asterisks indicate an anterograde virion stopping and changing to a retrograde direction. See
also Video S1. (B) Kymograph of the corresponding movie with a retrograde CAV-2 highlighted in blue. The viral particle labelled by the asterisk in
(A) is in red. (C) Displacement graph of 4 independent movies (46 carriers in total). CAV-2 showed a preferential retrograde transport, with only few
anterogradely-transported viral particles. (D) Speed distribution profile of CAV-2 in MNs. Blue line: 40 retrograde carriers, 398 single movements. Red
line: 6 anterograde carriers, 50 single movements (3 independent experiments). (E) Transported endocytic structures containing CAV-2 were revealed
by AlexaFluor647-labelled dextran (false coloured in green) and quantified in (F) (3 independent experiments, 73 carriers in total. Error bars represent
9.6%). Scale bars: 5 mm.
doi:10.1371/journal.ppat.1000442.g002
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PLoS Pathogens | www.plospathogens.org 5 May 2009 | Volume 5 | Issue 5 | e1000442Figure 3. CAV-2 transport in nonacidic retrograde carriers in MN axons. MNs were incubated with CAV-Cy3 and AlexaFluor488-TeNT HC for
45 minutes, fixed and imaged (A) or imaged live (B). (A) CAV-2 and TeNT HC colocalise in neurites (asterisk) and cell bodies (arrowhead) of MNs. (B)
Live cell imaging of MNs co-incubated with CAV-Cy3 and AlexaFluor488-TeNT HC. Individual frames of a movie are shown. The cell body is located to
the left. Arrowheads point to a TeNT HC carrier that is also positive for CAV-2. Greater than 85% of CAV-2 vesicles contained TeNT HC (4 independent
experiments, 40 carriers in total). See also Video S2. (C) and (D) MNs were incubated with CAV-CF for 45 minutes and imaged live. (C) pH calibration
curve of CAV-2 structures after treating MNs with ionophores and L15 adjusted at different pHs. Red curve is the best fitting curve, with R
2=0.9888. 2
independent experiments. Error bars represent 0.22 (pH 5), 0.0008 (pH 6), 0.026 (pH 7) and 0.11 (pH 8). (D) pHs of somatic versus axonal CAV-CF
containing organelles (21 and 33 virions respectively, 2 independent experiments). Each point represents a single CAV-CF-positive structure. The red
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N133I strongly impaired CAV-2
movement (Figure 4G and H), compared to overexpression of
GFP or GFP-Rab7
WT (Figure 4G and H). In agreement with
previous reports [48], the inhibitory effect of GFP-Rab7
N133I is
linked to its expression levels. As a consequence, sub-threshold
GFP-Rab7
N133I expression did not alter the axonal transport of
CAV-2 (Figure 4H; outlier in the GFP-Rab7
N133I sample).
Conversely, strong overexpression of GFP-Rab7
WT caused a
partial, yet not significant, inhibition of this process (Figure 4H).
These results suggest that Rab5 to Rab7 vesicular maturation is
required for CAV-2 progression along the axonal endocytic
pathway.
The axonal transport of CAV-2 relies on kinesin-1 and
cytoplasmic dynein motor activities
Axonal transport is mainly powered by the microtubule-dependent
motors cytoplasmic dynein and kinesins [34]. To further understand
the determinants of bidirectional CAV-2 transport, we stained MNs
previously incubated in the presence of CAV-Cy3 with antibodies
specific for subunits of motor complexes. Dynein heavy chain
(Figure 5A) and p50/dynamitin, a subunit of the dynein-dynactin
complex (data not shown), were associated with more than 60% of
virions, suggesting that this ubiquitous retrograde motor plays a
major role in the axonal transport of CAV-2. Secondly, we found a
lower, albeit significant, colocalisation of virions with the heavy chain
of kinesin-1 (KHC) (Figure 5B). Although these data do not exclude
the possibility that the bidirectional transport of CAV-2 is due
uniquely to dynein, they favour the likelihood that both cytoplasmic
dynein and kinesin play a role in thisprocess.To directly demonstrate
the involvement of these motor proteins in CAV-2 transport, we
overexpressed p50/dynamitin, a treatment that disrupts endogenous
dynein-dynactin complex [49]. In p50/dynamitin-expressing MNs,
CAV-2 transport was strongly inhibited (Figure 5C and F) compared
to GFP-expressing cells (Figure 5E). Similarly, overexpression of the
tetratricopeptide (TPR) domain of kinesin light chain 1 [50] also
reduced the frequency of motile virions (Figure 5D and F), suggesting
that the axonal transport of CAV-2 require coordination between
plus and minus-end microtubule motors.
CAV-2 and CAR colocalise on axonal carriers
Although the binding of Ads to CAR may induce downstream
signalling [51], CAR’s role in Ad infection has been considered
primarily as a docking site prior to integrin-mediated internalisa-
tion. Consistent with this, deletion of CAR cytoplasmic tail had no
significant effect on Ad internalisation in epithelial cells [52]. Yet,
CAV-2 is one of a handful exceptions in the Adenoviridae family: the
external capsid, in particular the penton base, does not contain a
recognisable integrin-interacting motif [16,53,54]. Therefore, we
asked whether CAV-2 and CAR were associated during
endocytosis and the subsequent axonal transport. As mentioned
previously, CAR staining in MNs showed a plasma membrane as
well as an intracellular localisation (Figure S1A). After 45 minutes
post-internalisation, 80% of axonal CAV-2 was found in CAR
+
structures (Figure S3). Furthermore, upon incubation of MNs with
TeNT HC and CAV-2, followed by an acid wash to remove
extracellular-bound ligands whilst preserving internalised probes
[44], anti-CAR immunostaining revealed high colocalisation levels
of CAR, CAV-2 and TeNT HC in neurites (,70%; Figure 6A).
The colocalisation of CAV-2 and TeNT HC in axonal carriers
prompted us to use a biochemical approach based on TeNT HC-
coupled to superparamagnetic nanobeads to isolate these transport
vesicles [44]. Using western blot analysis, we detected an ,250-
fold enrichment of CAR in these organelles (Figure 6B), further
supporting the notion that CAR and CAV-2 co-inhabit a pool of
axonal transport vesicles.
CAR endocytosis is linked to the axonal transport
machinery
To directly monitor CAR neuronal trafficking, we used
fluorescently-labelled CAV-2 fibre knobs (FK-Cy5 and FK-Cy3)
to visualise CAR entry and transport in MNs. Initially, we tested
the specificity of labelled-FK binding to CAR by transfecting
CAR-negative NIH 3T3 cells with a plasmid encoding a GFP-
CAR fusion protein. Transfected cells were then incubated with
FK-Cy5 and fixed. We found that only GFP
+ cells bound FK-Cy5,
strongly supporting a CAR-specific binding of the CAV-2 fibre
knob FK-Cy5 (Figure S4A). Consistently, preincubation of MNs
with unlabelled FK blocked FK-Cy5 labelling (Figure S4C). When
MNs were incubated with FK-Cy5 followed by acid wash, FK and
CAR colocalised in discrete puncta (.95%, Figure 7A), suggesting
that this viral protein and its cellular receptor are linked during
endocytosis. Furthermore, FK-Cy5 was retrogradely transported
in the same carriers as TeNT HC and displayed a bidirectional
transport similar to CAV-2 (Figure 7B), suggesting that CAR-
mediated binding and internalisation is coupled to axonal
transport. Accordingly, we also found FK-Cy5 in GFP-Rab7
+
axonal carriers (data not shown).
To further understand the role of CAR in CAV-2 binding and
endocytosis, we took advantage of a CAR-ablated FK variant
(FKm), which bears a single-point mutation in the CAR binding
site [15]. We incubated MNs on ice with labelled-FK or FKm. In
these conditions, FKm was not able to bind MNs (Figure S4B).
Together, these results strongly suggest that in neurons, CAR can
be endocytosed and trafficked bidirectionally in axons, and that
this protein may dictate internalisation and subsequent axonal
transport of CAV-2.
CAR is transported in axons of the sciatic nerve in vivo
The above results suggest that Ads take advantage of an innate
trafficking of CAR to access the CNS. This prompted us to
investigate its intracellular dynamics in vivo. Sciatic nerve ligation
represents a powerful system to study axonal dynamics. To
specifically monitor CAR axonal transport, we injected FK-Cy3 in
the tibialis anterior and gastrocnemius muscles of C57BL/6 mice
after ligation of the sciatic nerve. Eight hours post-injection, we
examined the distributions of CAR and FK-Cy3. Consistent with
our hypothesis, CAR accumulated inside axons in both proximal
and distal parts of the ligation site (Figure 8A). However, only
distal sections showed a clear signal correspondent to retrogradely-
transported FK-Cy3 (Figure 8A, right panel). Intra-axonal CAR
was also observed by staining for CAR in transverse sections of
unligated sciatic nerve (Figure 8B). CAR distribution was not
significantly affected by the presence of FK-Cy3 since similar CAR
staining patterns were also observed in the absence of FK
and blue horizontal lines are the mean pHs of the two pools of organelles. (E) and (F) MNs were incubated with CAV-Cy3, AlexaFluor488-Lysotracker
and/or AlexaFluor 647-dextran for 45 minutes and imaged live. (E) Kymographs showing that dextran-containing CAV-2 carriers are nonacidic. (F)
Acidic structures containing CAV-2 in the cell body of a MN. Quantitative analyses of CAV-2 structures association with acidic compartments: in the
cell body of MNs (4 independent experiments, 163 (cell body) and 211 (neurites) virions in total. Error bars represent 13.6% (CB) and 1.9% (neurites)).
Scale bars: (A, B) 5 mm; (F) 10 mm.
doi:10.1371/journal.ppat.1000442.g003
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PLoS Pathogens | www.plospathogens.org 8 May 2009 | Volume 5 | Issue 5 | e1000442(Figure 8A left panel, B, and data not shown). These data suggests
that CAR undergoes constitutive bidirectional transport in sciatic
nerve in situ.
Discussion
A better understanding of the interactions between adenovirus
and neurons was essential and overdue. To our knowledge, this is
the first study to address the determinants of Ad neurotropism and
axonal transport. Axonal transport has been described for a
handful of viruses, including rabies, herpes simplex type I (HSV-1),
measles, West Nile and poliovirus. Although less common than the
above pathogens, both human and canine Ad serotypes are
associated with brain pathologies [3,4]. Notably different mech-
anisms of axonal transport have been described: direct interaction
with molecular motors for HSV-1 and rabies viruses [55] versus
endosomal trafficking for poliovirus [56].
Our proposed model goes partially against the paradigm
derived from prototype Ad trafficking studies performed in
epithelial cells. We propose that the recognition of CAV-2 on
the neuronal surface is primarily CAR-dependent. Internalisation
involves CAR and clathrin-coated vesicles that acquire the early
endosomal marker Rab5, yet apparently does not induce capsid
disassembly and endosomal escape. These latter axonal vesicles
mature into Rab7
+ compartments that still contain CAR, and
have the advantageous characteristic of being nonacidic. After a
lag phase, long-range transport of CAV-2 entrapped in vesicular
organelles becomes sustained and bidirectional, probably involving
the concerted action of dynein and kinesin. Crucially, our data
also suggest an innate function of CAR in axons dictating CAV-2
transport.
Endocytic progression is required for Ad infection and has been
shown to differ mechanistically for different Ad serotypes [28].
The lag phase observed before the onset of CAV-2 axonal
transport, which is not seen in epithelial cells infected by CAV-2 or
Ad2/5 [30,39], was also similar to that observed for TeNT HC
and p75
NTR [44]. Although further studies will be needed to
pinpoint the underlying causes of this delayed onset, a likely
explanation is that it is due to cargo sorting and/or endosome
maturation. The association of CAV-2 initially with Rab5
+ early
endosomes and then with a transport compartment containing
Rab7 is also similar to TeNT HC trafficking. Interestingly, Rab7
effectors RILP and ORP1L can mediate the recruitment of
cytoplasmic dynein to endosomes in HeLa cells [57]. Whether
Rab7 also directly recruits the dynein complex in axons is
unknown, but might explain why, by reaching organelles
containing Rab7, CAV-2 undergoes efficient axonal transport.
Although other serotypes can reach Rab7
+ compartments [45],
there appears to be a functional difference between some of those
found in axons and epithelial cells, one difference being that a
population of Rab7
+ endosomes in axons have lumens that are
neutral. Using a marker described to traffic inside pH-neutral
carriers (TeNT HC), CAV-2 linked to a pH-sensitive dye [43] and
Lysotracker, we showed that in contrast to virions in the cell body
that can reach acidic organelles (pH 5–5.5), the majority of axonal
CAV-2 carriers had a pH ranging from 6 to 7. These data,
combined with previous report of the pH of axonal organelles [58]
demonstrate that the presence of Rab5 and Rab7 offer no
indication of the pH of the endosomes or other organelles under
investigation. Neurons appear to differ in the regulation of
endosomal acidification that occur in their axons versus cell body.
By entering nonacidic organelles in axons, CAV-2 could remain
stably and efficiently associated with long-range carriers until
delivered to the soma, where endosomal acidification could occur,
triggering the exit from these compartments.
In light of these results, it is tempting to speculate that human
Ad serotype 5 (HAd5), which can be retrogradely transported in
vivo [31,32] and escapes endosomes when the pH drops below 6 in
epithelial-like cells [45], could take advantage of a similar
protective endocytic pathway to reach the neuronal cell body.
Interestingly, when HAd5 and CAV-2 vectors were mixed and co-
injected in the rodent brain, both are capable of axonal transport
to afferent regions. However CAV-2 vectors are 50–100 fold more
efficient when transgene expression is used as a readout at distal
sites [7]. Does HAd5 use a pathway similar to CAV-2? There are
notable similarities and differences between HAd5 and CAV-2
that may affect their axonal transport. In the case of CAR as a
binding site, our data have consistently suggested that CAV-2 is
‘‘CAR-tropic’’ while other studies have reported that HAd5 uses
CAR, as well as other cell surface molecules for binding and
internalisation [37]. CAV-2 is also more thermostable than HAd5
(unpublished data). A priori, we would predict that if an HAd5
virion binds CAR it could be taken up and transported in a
manner similar to that seen by CAV-2. Using real time confocal
microscopy we detected fast axonal transport of HAd5 in primary
neurons (our unpublished data) suggesting, but not demonstrating,
similarities in transport. We do not know if the increased thermal
stability of CAV-2 versus HAd5 plays a role during vesicular
maturation at, for example, the axon soma interface. The
interaction with integrins via the HAd5 penton base may also
make the HAd5 capsid more sensitive to disassembly triggers in
the lumen of a Rab7 vesicle in axons.
The motility of CAV-2 showed an average retrograde speed
above 1 mm/s, consistent with fast axonal transport. Notably, we
found a minor population of CAV-2 and FK carriers undergoing
bidirectional transport. Similar bidirectional transport was detect-
ed using FK to monitor CAR trafficking in axons. This feature is
not unique to Ad: HSV-1 shows bidirectional transport with a bias
for the retrograde direction during infection and displays a
preferential anterograde transport during the phase of egress
[55,59]. However, bidirectional HSV-1 transport is via direct
Figure 4. Endosomal maturation during internalisation and transport of CAV-2. (A) MNs were incubated with CAV-Cy3 for 5 minutes at
37uC and stained for endogenous Rab5 and Rab7. The arrow shows CAV-2 present in a Rab5-positive organelle. (B) Immunofluorescence experiments
show that 45 minutes post-entry, CAV-2 is present mainly in endosomes containing only Rab7 (asterisk). (C) Quantification of 3 independent
experiments shows progression along the endocytic pathway during CAV-2 entry and transport (5 minutes, 141 virions; error bars represent 9%
(neither), 11.3% (Rab5), 3.8% (Rab5+7) and 3% (Rab7); 45 minutes, 171 virions; error bars represent 3.1% (neither), 3.1% (Rab5), 6.9% (Rab5+7) and
5.9% (Rab7)). (D) and (E) MNs were microinjected with an expression plasmid encoding GFP-Rab7
WT and imaged live after CAV-2 infection. (D) GFP-
Rab7
WT is localised on a vesicular compartment distributed in the soma and neurites. CAV-2 is associated with GFP-Rab7
WT-positive organelles in cell
bodies and neurites (asterisks). (E) Live cell experiment showing CAV-2 transport in an axonal GFP-Rab7
WT-positive carrier (arrowhead). (F)
Corresponding kymograph. (G) MNs expressing the dominant-negative GFP-Rab7
N133I mutant were imaged live after CAV-2 infection. Representative
kymograph shows strong reduction of CAV-2 transport. An example of a CAV-2 carrier resuming bidirectional transport after a long pause is
highlighted in red, whilst a stopped virion is in green. (H) Quantification of the effects of GFP, GFP-Rab7
WT and GFP-Rab7
N133I expression on CAV-2
transport. At least 3 independent experiments were performed for each condition (112 (GFP), 107 (GFP-Rab7
WT) and 45 (GFP-Rab7
N133I) virions in
total. Scale bars: (A, B, E) 5 mm; (D) 10 mm.
doi:10.1371/journal.ppat.1000442.g004
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2 and CAR with organelles undergoing bidirectional movement is
particularly interesting because the regulation of bidirectional
transport is still poorly understood. In this regard, CAR- or CAV-
2-containing endosomes could represent an ideal tool to address
how vesicular cargo coordinates the recruitment of both classes of
microtubule-dependent molecular motors, or how a main
retrograde motor, such as cytoplasmic dynein, may switch to an
Figure 5. Cytoplasmic dynein and kinesin-1 drive axonal CAV-2 transport in MNs. MNs were incubated for 45 minutes with CAV-Cy3, fixed
and stained for molecular motor components. (A) Dynein heavy chain (DHC) colocalises with CAV-2 in MN axons (arrowheads show double-positive
structures). Quantification is shown on the right (3 independent experiments, 168 virions in total; error bars represent 5.2%). (B) Kinesin heavy chain
(KHC) is associated with a subpopulation of CAV-2 (arrowheads). Quantification of 3 independent experiments is shown on the right (83 virions in
total; error bars represent 1.14%). (C–F) MNs were microinjected with either GFP or GFP-p50 or GFP-TPR expression plasmids and imaged live after
CAV-Cy3 infection. Representative kymographs show a strong inhibition of CAV-2 transport in either GFP-p50-expressing (C) or GFP-TPR-expressing
(D) MNs. An example of a CAV-2 carrier resuming bidirectional transport after a pause is highlighted in red, whilst stopped virions are in green. (E)
Kymograph of a GFP expressing neuron showing normal CAV-2 transport. (F) Quantification of the effect of inhibiting cytoplasmic dynein and kinesin
1 on CAV-2 axonal transport. A minimum of 3 independent experiments was performed for each condition; 112 (GFP), 54 (p50) and 52 (TRP) virions in
total. Scale bars: (A) 5 mm; (B) 10 mm.
doi:10.1371/journal.ppat.1000442.g005
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of kinesin- and dynein-driven transport since it is able to
simultaneously bind these two classes of motors. Interestingly,
p50/dynamitin, a subunit of the dynactin complex, colocalised
with CAV-2, and p50/dynamitin overexpression inhibited the
axonal transport of virions. The observed impairment of CAV-2
transport by inhibition of either cytoplasmic dynein or kinesin-1
suggests that coordination between these two classes of motors is
necessary to ensure efficient axonal retrograde transport, as
previously observed for TeNT HC carriers and mitochondria
(reviewed in [33]).
A priori, one could envisage that the internalised cargo, via its
interaction with specific integral membrane proteins, dictates the
directionality of the transport. In this light, although TeNT HC and
CAV-2 share a high number of axonal carriers, together they move
exclusively in the retrograde direction. In contrast, anterograde
moving organelles contain CAR and CAV-2, but lack TeNT HC.
This observation suggests the existence of discrete sorting steps
during internalisation or en route endosomal maturation, which alter
the ability of transported endosomes to recruit or activate
anterograde and/or retrograde motor complexes. This may be
achieved by engaging specific adaptor proteins able to co-ordinate
motor complex activity, as in the case of huntingtin, which controls
the directionality of vesicular carriers in cortical neurons via an Akt-
dependent phosphorylation switch [60].
Although CAR is the main receptor for many Ad serotypes,
little is known regarding its intracellular dynamics in neurons. In
addition to a plasma membrane targeting, we found that CAR is
also present on an internal vesicular pool. By means of competition
experiments, we showed that the binding to CAR is an essential
Figure 6. CAV-2 and CAR colocalise in axonal endosomes. (A) CAR colocalises with CAV-2 and TeNT HC in MNs. Acid-washed MNs incubated
with CAV-Cy3 and AlexaFluor488-TeNT HC for 45 minutes show internal virions in compartments containing CAR and TeNT HC (arrowheads) in MN
axons. Quantification is shown on the right panel (3 independent experiments, 95 carriers in total; error bars represent 7.3%). (B) Magnetic pull-down
of TeNT HC-containing vesicles. MNs were incubated with TeNT HC coupled to superparamagnetic Fe beads for 60 minutes and then lysed in absence
of detergent (see Materials and Methods). A representative experiment (left panel) and its quantification (right panel, 3 independent experiments) are
shown. Western blot analysis after magnetic purification shows a specific association of CAR with TeNT HC transport carriers. Scale bars=10 mm.
doi:10.1371/journal.ppat.1000442.g006
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taken up in CAR-containing vesicles, suggesting that the virus and
its receptor could be endocytosed together and then co-
transported. Notably though, our assays do not address whether
fibres detach from the capsid, which is an early step in virion
disassembly in epithelial cells [28]. Given the average size of CAV-
2
+ vesicles (100–110 nm) versus the CAV-2 icosahedra core
(,90 nm [61] plus the projecting fibres (30 nm)), the most obvious
prediction is that the fibres would be detached. However, the
CAV-2 fibre shaft, in contrast to other Ads [36], is particularly
flexible due to the presence of two hinges [61]. This added
suppleness may allow the fibre to fold over whilst still attached to
CAR in the lumen of the endosomes.
By using fluorescently-labelled CAV-2 FK, we also demonstrat-
ed that CAR undergoes endocytosis and bidirectional transport in
cultured MNs and in sciatic nerve axons. These findings introduce
a paradigm shift for the CAR-mediated endocytosis of Ads. As
mentioned above, the available in vitro evidence is that CAR
functions as a primary attachment site and that integrins are
responsible for virus internalisation via the interaction with motifs
in the Ad penton base. The homotrimeric FK could bind three
CAR D1 domains simultaneously [13,15,62]. In this light, it will
be critical to determine if the FK induces clustering of CAR, which
in turn triggers internalisation of ligand-receptor clusters, or if
other mechanisms are involved. Interestingly, the affinity of the
CAV-2 FK to CAR is 5 to 7-fold times greater than that of HAd5
knob-CAR and the highest reported for an Ad [15].
The roles of CAR as an adhesion molecule and key component
of tight junctions are well established [18]. Although CAR is
highly expressed in the developing brain [17], its neuronal
function(s) remains speculative. Based on its direct interaction
with actin, a potential role of CAR in neurite outgrowth has been
proposed [63]. Recently, this association has been extended to
several cytoskeletal components, suggesting a more general role of
Figure 7. CAR internalisation and bidirectional transport in neurons. (A) MNs were incubated with FK-Cy5 (pseudo-coloured in red) for
45 minutes, acid washed, fixed and stained for endogenous CAR. FK and CAR colocalise in a vesicular compartment in the cell body and axons of MNs
(.95%, 3 independent experiments, 412 FK structures in total). (B) MNs were incubated with FK-Cy5 (pseudo-coloured in red) and AlexaFluor488-
TeNT HC for 45 minutes and imaged. Still images of a movie are showed. Arrowhead shows a retrograde carrier containing both FK and TeNT HC; the
asterisk shows an anterograde organelle containing FK. A kymograph showing the bidirectional transport of FK in the right part of panel B. Scale bars:
(A) 10 mm; (B) 5 mm.
doi:10.1371/journal.ppat.1000442.g007
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vivo and in vivo data demonstrate that CAR is found inside axons
even in absence of an exogenous ‘‘ligand’’, and also link CAR
directly or indirectly to the axonal transport machinery. Together,
our observations suggest that CAV-2 is taking advantage of an
axonal trafficking pathway involving CAR and that allows virions
to be efficiently transported to the CNS.
The nature and regulation of axonal transport pathways are of
crucial interest since their impairment has been linked to several
neurodegenerative disorders. In this context, some Rab7-associat-
ed axonal organelles may be the hallmark of a long-range,
vectorial axonal transport. Because CAV-2, like TeNT, is able to
reach this compartment, it may have a preferential and efficient
access to the CNS. Indeed, this Rab7
+ nonacidic axonal
Figure 8. CAR transport in sciatic nerve axons. (A) To monitor axonal transport of CAR in vivo, FK-Cy3 was injected into the tibialis anterior and
gastrocnemius muscles after ligation of the sciatic nerve. A representative experiment is shown. FK was only found in axons in the distal part of the
ligature (right panel; see also the scheme of the experiment on the top part of the figure). These axons are positive for CAR (right panel; in green;
arrows). CAR accumulates also at the proximal side, suggesting that it undergoes bidirectional transport in vivo. FK was undetectable on the proximal
side of the ligation (left panel; in red). (B) Transverse section of an unligated sciatic nerve shows intra-axonal CAR. Myelin basic protein (MBP) delimits
axons. Scale bars: (A) 10 mm; (B) 5 mm.
doi:10.1371/journal.ppat.1000442.g008
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during long-range transport, allowing pathogens, virulence factors,




All experiments were carried out under license from the UK
Home Office in accordance with the Animals (Scientific
Procedures) Act 1986 and following approval from the Cancer
Research UK Ethical Review Committee.
Materials and neuronal cultures
Labelling reagents, AlexaFluor488-Lysotracker, AlexaFluor647-
dextran, carboxyfluorescein and AlexaFluor-conjugated secondary
antibodies were from Invitrogen. Mouse monoclonal anti-CAR
antibody (MoAb.E(mh); a gift from Steven Carson, University of
Nebraska) was used at 1:500 in western blot analyses. Rabbit
polyclonal anti-CAR antibodies (1:300) (Ab1605; a gift from
Joseph Zabner, University of Iowa), monoclonal anti-Rab5 (1:200;
Synaptic System), polyclonal anti-Rab7 (1:200) [44], polyclonal
anti-FK (1:300) [65], anti-DHC (1:100; Santa-Cruz) anti-p50/
dynamitin (1:200; BD Bioscience), anti-KHC (1:100; Chemicon)
were used in immunofluorescence (IF) studies. Monoclonal anti-
Cy3 (1:200; Abcam) was used on live cells. Anti-MBP was
purchased from Boehringer (Mannheim, Germany). p50/dyna-
mitin and TPR construct were kindly provided by Michael Way
(CRUK, London). The plasmid expressing GFP and CAR was a
gift from Joseph Zabner. Paramagnetic Fe-beads were purchased
from G. Kisker GbR. Rat spinal cord MNs were purified from
E13.5 embryos as described previously [43] and used from day in
vitro 5 onwards.
Vectors and viruses
CAV-Cy3 was prepared from the E1-deleted vector CAVGFP
[66] by direct post-purification labelling with Cy3 [39]. CAV-Cy3
has a physical particle (pp) to infectious unit (IU) ratio of 25:1 [66].
The vector was propagated, purified, and titred as previously
described [7,66]. Multiplicities of infection are in pp/cell.
Immunofluorescence, live cell imaging and data
quantification
For internalisation assays, MNs were incubated with CAV-Cy3
on ice and either fixed or shifted to 37uC for 45 minutes, back on
ice, incubated with anti-Cy3 to label cell-surface virions and then
fixed. Indirect immunofluorescence (IF) experiments were per-
formed as follow. After fixation, MNs were permeabilised with
0.1% Triton X-100 for 5 minutes at room temperature (RT),
followed by blocking with 3% bovine serum albumin (BSA) for
1 hour at RT. Primary and secondary antibodies were diluted in
blocking solution and incubated sequentially for 1 hour at RT.
Samples were then mounted with Mowiol (Harco) and imaged by
confocal microscopy. For live cell experiments, MNs were
incubated with CAV-Cy3 and AlexaFluor488-TeNT HC or
AlexaFluor647-dextran or AlexaFluor488-Lysotracker at 37uC,
washed with DMEM containing 30 mM HEPES-NaOH, pH 7.4
and imaged. Live and fixed samples were imaged by confocal
microscopy (Zeiss LSM 510 equipped with a 636, 1.4 NA Plan
Apochromat oil-immersion objective). Images were processed
using Zeiss LSM 510 software. For live cell imaging, 100–150
frames were acquired (0.2 frames/s) and analysed as previously
described [42]. Kymographs were generated using MetaMorph
(Molecular Devices). Vertical single line-scans through the
thickness of each process were plotted sequentially for every
frame in the time series. Acid wash was performed to release
proteins bound to the cell surface by incubating the cells for
5 minutes at room temperature in 100 mM citrate-NaOH,
pH 2.0, 140 mM NaCl and washed with PBS. Virus binding
was quantified using the spot count option of the Imaris software
and normalized to the total amount of membrane measured by
voxel counting using ImageJ.
Intracellular pH measurement
CAV-2 was directly labelled with carboxyfluorescein according
to a previous report [45]. Briefly, carboxyfluorescein can be used
as intracellular pH sensor by measuring the ratio of emission
intensities upon sequential excitation at 458 and 488 nm (I
488/
I
458). CAV-CF-infected MNs were imaged live and after obtaining
the calibration curve (with MNs treated with 10 mg/ml of nigericin
and monensin+L15 at various pHs), axonal versus somatic
particles emission intensities were analysed. Intensities and ratios
were measured using imageJ (version 1.37).
Magnetic isolation of axonal retrograde carriers and
image quantification
Magnetic isolation of TeNT HC carriers was performed as
previously described [44]. Quantification of CAR enrichment in
carriers by western blot was performed using ImageJ.
Recombinant proteins and fluorescent labelling
TeNT HC was isolated and labelled as previously described
[44]. CAV-2 FK (residues 358–542) construct was cloned into
pPROEX HTb (Life Technologies), expressed with a cleavable
His6-tag, and purified as previously described [15]. The CAV-2
FKs were dialysed in PBS 0.1 M Na2CO3 pH 9.3 and labelled
using Cy5 mono-reactive dye pack (Amersham Bioscience) for
45 minutes at RT. The elution of labelled protein was performed
with 2 ml of PBS using NAP5 column (GE Healthcare) pre-
equilibrated with 10 ml PBS. The final dye/protein ratio (,2.4)
was determined using a NanoDrop ND-100 spectrophotometer.
Transmission electron microscopy (TEM)
For TEM analysis, MNs were incubated for various time
periods with CAV-Cy3. Cells were washed twice with 0.2 M
Sorensen’s buffer and fixed with 2.5% glutaraldehyde (Agar) in
Sorensen’s buffer, containing 70 mM sucrose for 1 h at 4uC. After
washing, MNs were post-fixed with 1% osmium tetroxide for
30 minutes, washed, dehydrated in an ascending ethanol series
and embedded in araldite over 2 days. Thin sections were stained
with methanolic uranyl acetate and lead citrate. Sections were
imaged with a JEOL 1010 transmission electron microscope.
Sciatic nerve ligation and intramuscular injection of FK-
Cy5
Under isoflurane anaesthesia (National Veterinary Services,
Stoke on Trent, UK), an incision was made along the left flank of
adult C57Bl/6 mice to expose their sciatic nerve, which was
ligated at the mid-thigh level. Immediately following ligation, the
tibialis anterior and gastrocnemius muscles were exposed and FK-
Cy5 (6 mgi n8ml) was slowly injected intramuscularly using a
Hamilton microsyringe. The needle was left in place for 1 minute
to prevent leakage. The wound was sutured and the animals were
allowed to recover. After approximately 8 hours, the mice were
terminally anaesthetized with sodium pentobarbitone and per-
fused transcardially with 4% PFA (TAAB) in 0.1 M PBS. The
ligated sciatic nerve was removed, post-fixed for 4 hours in the
Axonal Transport of CAV-2
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animals were housed in a controlled temperature and humidity
environment and maintained on a 12 hour light/dark cycle with
access to food and water ad libitum.
Supporting Information
Figure S1 CAR neuronal localisation and CAV-2 entry. (A).
Primary MNs in culture were fixed, permabilised and fixed for
endogenous CAR. a- Confocal analyses showed internal structures
containing CAR in MN. Left panel shows z-stacks of a MN.
Asterisks highlight internal CAR. b and c- Epithelial-like cells in the
culture displays only cell-to-cell contact localisation of CAR. (B)
MNs were incubated on ice with CAV-Cy3, fixed and stained by
indirect immunofluorescence for CAR. Axons display some
punctate staining of CAR that colocalise with CAV-2. (C) Cells
treated with CAV-2 for 1 minute were fixed and imaged by TEM.
White arrow shows a structure ressembling a clathrin-coated pit. (D)
MN were incubated for 2 min with CAV-2-Cy3, fixed and stained
for clathrin heavy chain (CHC). Arrowheads show virions associated
with CHC. Scale bar: (A and B) 10 mm( C )1 0 0n m( D )5mm.
Found at: doi:10.1371/journal.ppat.1000442.s001 (1.75 MB PDF)
Figure S2 Kinetics of CAV-2 retrograde transport. MNs were
incubated with CAV-Cy3 and imaged. Kymographs of CAV-2
transport after 15, 25 and 35 min of internalisation show that the
onset of transport occurs after an initial lag phase of 25–30 min.
Red dots highlight a still carrier (15 min after internalisation) and
a long range transported carrier (35 min after internalisation).
Found at: doi:10.1371/journal.ppat.1000442.s002 (0.11 MB PDF)
Figure S3 CAV-2 is endocytosed with CAR. MNs were
incubated CAV-Cy3 for 45 min, fixed and stained for CAR.
The majority of CAV-2 was found together with CAR
(arrowheads) (.77% 138 particles, 3 independent experiments.
Error bar represent 5.5%). Scale bar: 5 mm.
Found at: doi:10.1371/journal.ppat.1000442.s003 (0.15 MB PDF)
Figure S4 CAV-2 Fibre Knob (FK) recognises specifically CAR.
(A) NIH 3T3 cells were transfected wit GFP-CAR and incubated
with Cy5-FK. Only CAR-expressing cells were able to bind FK.
(B) FK mutated in the CAR binding site (FKm) does not bind
MNs. MNs were incubated on ice with FK or FKm, washed and
then fixed prior to confocal imaging. Membranes were revealed by
wheat germ agglutinin (WGA). (C) FK-Cy5 binds specifically to
the MN surface. MNs were incubated with FK-Cy5 with or
without pre-incubation with saturating concentration of unlabelled
FK. Scale bars: (A, C) 10 mm, (B) 20 mm.
Found at: doi:10.1371/journal.ppat.1000442.s004 (0.76 MB PDF)
Video S1 Scanning confocal imaging of CAV-2 infected motor
neurons.
Found at: doi:10.1371/journal.ppat.1000442.s005 (5.55 MB AVI)
Video S2 Scanning confocal imaging of CAV-Cy3 and TeNT
Hc-Alexa488 in motor neuron axons.
Found at: doi:10.1371/journal.ppat.1000442.s006 (10.31 MB
AVI)
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